


下載本文檔
版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemESildenafil citrateCat. No.: HY-15025ACAS No.: 171599-83-0Synonyms: UK-92480 citrate分式: CHNOS分量: 666.7作靶點(diǎn): Phosphodiesterase (PDE); Autophagy作通路: Metabolic Enzyme/Protease; Autophagy儲(chǔ)存式: Powder -20C 3 years4C 2 yearsIn solvent -8
2、0C 6 months-20C 1 month溶解性數(shù)據(jù)體外實(shí)驗(yàn) DMSO : 29 mg/mL (43.50 mM)H2O : 2 mg/mL (3.00 mM; Need ultrasonic)* means soluble, but saturation unknown.Mass Solvent1 mg 5 mg 10 mg Concentration制備儲(chǔ)備液1 mM 1.4999 mL 7.4996 mL 14.9992 mL5 mM 0.3000 mL 1.4999 mL 2.9998 mL10 mM 0.1500 mL 0.7500 mL 1.4999 mL請(qǐng)根據(jù)產(chǎn)品在不同溶劑中
3、的溶解度,選擇合適的溶劑配制儲(chǔ)備液,并請(qǐng)注意儲(chǔ)備液的保存式和期限。BIOLOGICAL ACTIVITY物活性 Sildenafil citrate種有效的磷酸酯酶 5 (PDE5)抑制劑,IC50 為 5.22 nM。IC50 & Target IC50: 5.22 nM (PDE 5) 11/3 Master of Small Molecules 您邊的抑制劑師www.MedChemE體外研究 Pretreatment with 1 M Sildenafil citrate potentiates the phosphorylation of ERK1/ERK2, an increase
4、in thepercentage of cells in S phase and cell proliferation, compared with serotonin stimulation alone (P 2.體內(nèi)研究 In the dog model of erection, Sildenafil citrate significantly increases ICP and ICP/BP but shows nosignificant effect on BP compared with vehicle 1. Sildenafil treatment significantly de
5、creases the number ofTL+-cells at 10 but not 0.5 mg/kg. At this time point, cells positive for the M1-like marker COX-2+ are found inthe ischemic core in PBS-treated animals, whereas they are mostly observed in the penumbra in 10 mg/kg(but not 0.5 mg/kg) Sildenafil-treated animals. In contrast, 8 da
6、ys after pMCAo the number ofmicroglia/macrophages stained by Iba-1 are significantly reduced by Sildenafil treatment (0.5 and/or 10mg/kg dose) 3. Sildenafil citrate has been reported to decrease flap necrosis in preclinical animal models byincreasing the secretion of growth factors (FGF and VEGF), a
7、nd histologically is shown to be effective in ratcavernous nerve architecture 4.PROTOCOLCell Assay 2 Cells at approximately 90% confluence are harvested with 0.1% trypsin/0.01% ethylene diamine tetraaceticacid (EDTA) solution and seeded into a 96-well plate at a density of 2104 cells/well and grown
8、in RPMI-1640 containing 10% FBS for three days, followed by serum starvation for three days. Cells are thenincubated for different time with various concentration of serotonin or 1 M Sildenafil followed by serotoninwith or without U0126, as indicated. Control cells are treated in the same way except
9、 sterile PBS replacedthe drug. After treatment, medium is changed to fresh medium, and cells are incubated with 5 g/L of MTT forfour hours. MTT is then dissolved with 150 L of 10% DMSO for 20 minutes. The optical densities (OD) in the96-well plates are determined using a microplate reader at 570 nm
10、2.MCE has not independently confirmed the accuracy of these methods. They are for reference only.Animal Mice 3Administration 34 Ischemia is induced in C57Bl/6 mice on postnatal (P) day 9 by permanent middle cerebral artery occlusion(pMCAo), and followed by either PBS or Sildenafil intraperitoneal (i
11、.p.) injections. In the first set ofexperiments, animals are randomly divided into five groups and treated with either PBS or a single dose ofSildenafil citrate (0.5, 2.5, 10, and 15 mg/kg), given intraperitoneally (i.p.) 5 min after pMCAo. In the secondset of experiments, animals are randomly divid
12、ed into three groups and treated with either PBS or a singledose of Sildenafil citrate (0.5 and 10 mg/kg, i.p.) 5 min after pMCAo.Rats 4Thirty male Sprague-Dawley rats weighing between 210 and 240 g are used. Rats from all groups areanesthetized with xylazine + ketamine and then a crush injury is cr
13、eated by using a one-minute long vascularclamp to the right sciatic nerve. One day before the procedure, rats from Group 1 are started on a 28-daytreatment consisting of a daily dose of 20 mg/kg body weight Sildenafil given orally via nasogastric tube,while the rats from Group 2 are started on an ev
14、ery-other-day dose of 10 mg/kg body weight Sildenafilcitrate. Rats from Group 3 did not receive any drugs. Subjects in all 3 groups are fed ad libitum with normalrat chow and tap water. Forty-two days after the nerve damage is created, the rats underwent a static sciaticindex (SSI) test, sedation an
15、d motor coordination tests, and accelerated rotarod tests. Rats are sacrificedunder anesthesia and their sciatic nerves are removed surgically. Histopathologic analyses of the nerves andbone densitometry evaluation of the extremities are then performed.2/3 Master of Small Molecules 您邊的抑制劑師www.MedChe
16、mEMCE has not independently confirmed the accuracy of these methods. They are for reference only.REFERENCES1. Wang Z, et al. The Selectivity and Potency of the New PDE5 Inhibitor TPN729MA. J Sex Med. 2013 Nov;10(11):2790-7.2. Li BB, et al. Sildenafil potentiates the proliferative effect of porcine p
17、ulmonary artery smooth muscle cells induced by serotonin in vitro.Chin Med J (Engl). 2011 Sep;124(17):2733-40.3. Moretti R, et al. Sildenafil, a cyclic GMP phosphodiesterase inhibitor, induces microglial modulation after focal ischemia in the neonatalmouse brain. J Neuroinflammation. 2016 Apr 28;13(1):95.4. Korkmaz MF, et al. The Effect of Sildenafil on Recuperation from Sciati
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 兵團(tuán)戶口管理辦法
- 養(yǎng)豬農(nóng)戶管理辦法
- 兼職監(jiān)理管理辦法
- 內(nèi)部對(duì)賬管理辦法
- 軍隊(duì)學(xué)員管理辦法
- 農(nóng)合住院管理辦法
- 農(nóng)改項(xiàng)目管理辦法
- 農(nóng)村小豬管理辦法
- 農(nóng)村竹林管理辦法
- 農(nóng)科驛站管理辦法
- 庫(kù)倫分析法課件
- 危險(xiǎn)源識(shí)別與風(fēng)險(xiǎn)評(píng)估說(shuō)明
- GRR表格MSA第四版完整版
- 文本信息加工和表達(dá)
- ks-s3002sr2腔全自動(dòng)清洗機(jī)規(guī)格書(shū)megpie
- 廠房改造工程施工組織設(shè)計(jì)
- 2023年錦州師范高等??茖W(xué)校高職單招(語(yǔ)文)試題庫(kù)含答案解析
- 歷年托福詞匯題匯總440題有答案
- 湘少版英語(yǔ)六年級(jí)下冊(cè)全冊(cè)教案
- 武漢城市介紹動(dòng)態(tài)模板課件
- 小升初語(yǔ)文文言文閱讀真題50題(含答案)
評(píng)論
0/150
提交評(píng)論